These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29548791)

  • 1. Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.
    White JA; Estrada M; Weldon WC; Chumakov K; Kouiavskaia D; Fournier-Caruana J; Stevens E; Gary HE; Maes EF; Oberste MS; Snider CJ; Anand A; Chen D
    Biologicals; 2018 May; 53():30-38. PubMed ID: 29548791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains.
    Cai W; Ping L; Shen W; Liu J; Zhang M; Zhou J; Peng J; Wang M; Zhu Y; Ji G; Wang X; Ji Q; Lai C; Shi L; Che Y; Sun M
    Hum Vaccin Immunother; 2020 Aug; 16(8):1866-1874. PubMed ID: 32118517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Kraan H; Ten Have R; van der Maas L; Kersten G; Amorij JP
    Vaccine; 2016 Aug; 34(38):4572-4578. PubMed ID: 27470209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
    Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
    J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.
    Stinson JA; Palmer CR; Miller DP; Li AB; Lightner K; Jost H; Weldon WC; Oberste MS; Kluge JA; Kosuda KM
    Vaccine; 2020 Feb; 38(7):1652-1660. PubMed ID: 31959422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for the Quality Control of Inactivated Poliovirus Vaccines.
    Wilton T
    Methods Mol Biol; 2016; 1387():279-97. PubMed ID: 26983741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
    Murakami K; Fujii Y; Someya Y
    Vaccine; 2020 Apr; 38(17):3295-3299. PubMed ID: 32197923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
    Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
    mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
    Anand A; Molodecky NA; Pallansch MA; Sutter RW
    Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement.
    Chen H; Gao Z; Bai S; Liu X; Han S; Xiao Y; Liu F; Yu Y; Sun H; Yang X
    Vaccine; 2021 Apr; 39(17):2467-2474. PubMed ID: 33810904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine.
    Sawyer LA; McInnis J; Patel A; Horne AD; Albrecht P
    Vaccine; 1994 Jul; 12(9):851-6. PubMed ID: 7526574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains.
    Kersten G; Hazendonk T; Beuvery C
    Vaccine; 1999 Apr; 17(15-16):2059-66. PubMed ID: 10217607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines.
    Honda-Okubo Y; Baldwin J; Petrovsky N
    Pathogens; 2021 Apr; 10(5):. PubMed ID: 33919442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.
    Macklin GR; Grassly NC; Sutter RW; Mach O; Bandyopadhyay AS; Edmunds WJ; O'Reilly KM
    Lancet Infect Dis; 2019 Oct; 19(10):1121-1128. PubMed ID: 31350192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Poliovirus Antigenicity by Surface Plasmon Resonance. Application for Potency Indicating Assays.
    Westdijk J; van der Maas L; Ten Have R; Kersten G
    Methods Mol Biol; 2016; 1387():299-323. PubMed ID: 26983742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.
    Muller DA; Pearson FE; Fernando GJ; Agyei-Yeboah C; Owens NS; Corrie SR; Crichton ML; Wei JC; Weldon WC; Oberste MS; Young PR; Kendall MA
    Sci Rep; 2016 Feb; 6():22094. PubMed ID: 26911254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.
    Bockstal V; Tiemessen MM; Achterberg R; Van Wordragen C; Knaapen AM; Serroyen J; Marissen WE; Schuitemaker H; Zahn R
    Vaccine; 2018 Nov; 36(46):6979-6987. PubMed ID: 30314910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: a randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy.
    Ferrera G; Cuccia M; Mereu G; Icardi G; Bona G; Esposito S; Marchetti F; Messier M; Kuriyakose S; Hardt K
    Hum Vaccin Immunother; 2012 Mar; 8(3):355-62. PubMed ID: 22327497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
    Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
    Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.